Interim data from ongoing Phase 1 clinical trial of WTX-330, further characterizing tolerability and activity profile, to be presented at SITC Annual Meeting – – Monotherapy and combination expansion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback